The Centers for Medicare & Medicaid Services in mid-November announced that Medicare will cover monoclonal antibody therapy for COVID-19 treatments.
The coverage will be available to beneficiaries who live across a variety of healthcare settings, including nursing homes, at no cost during the public health emergency.
The agency added that Medicare will cover and pay for the antibody infusions “the same way it covers and pays for COVID-19 vaccines,” once approved and ready for distribution. However, the federal program will not pay for products that providers receive for free.
From the December 2020 Issue of McKnight's Long-Term Care News
